Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to $20.5 million.

  • Tandem Diabetes Care's Cash from Investing Activities rose 20321.67% to $20.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $92.9 million, marking a year-over-year increase of 30601.21%. This contributed to the annual value of -$23.5 million for FY2024, which is 7261.25% up from last year.
  • Tandem Diabetes Care's Cash from Investing Activities amounted to $20.5 million in Q3 2025, which was up 20321.67% from $58.1 million recorded in Q2 2025.
  • Tandem Diabetes Care's Cash from Investing Activities' 5-year high stood at $58.1 million during Q2 2025, with a 5-year trough of -$76.8 million in Q4 2021.
  • Its 5-year average for Cash from Investing Activities is -$9.2 million, with a median of -$5.1 million in 2024.
  • Per our database at Business Quant, Tandem Diabetes Care's Cash from Investing Activities tumbled by 60661.92% in 2023 and then soared by 174209.04% in 2025.
  • Tandem Diabetes Care's Cash from Investing Activities (Quarter) stood at -$76.8 million in 2021, then soared by 146.57% to $35.8 million in 2022, then tumbled by 146.35% to -$16.6 million in 2023, then surged by 130.21% to $5.0 million in 2024, then surged by 309.9% to $20.5 million in 2025.
  • Its Cash from Investing Activities was $20.5 million in Q3 2025, compared to $58.1 million in Q2 2025 and $9.2 million in Q1 2025.